1. Your position in the FDA is? Yes, that's right!
Same as yours' I reckon. I've probably had my nose in more FDA procedures than you though.
2. They aren't St. Vincent De Paul. They aren't about to waste their time. You are saying (from your position of authority within the FDA - refer 1. above) that capability of applicants isn't taken into account? Are you sure about that?
No. You suggested that not me. I'm saying the capability of the applicants can be inferred from things much more to do with what the applicants are directly presenting to the FDA. Yes they aren't St Vincent De Paul. No they aren't about to waste their time.
Pretty sure. Yes.
3. You're a walking, talking, typing design flaw.
That won't waste more time on this though.
Ann: Cynata Expands trial in COVID-19 & Respiratory Failure, page-186
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
-0.005(2.50%) |
Mkt cap ! $35.20M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.0¢ | 19.5¢ | $1.705K | 8.654K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 12792 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 32500 | 1 |
View Market Depth
| Last trade - 10.02am 30/08/2024 (20 minute delay) ? |
| CYP (ASX) Chart |